Page last updated: 2024-09-04

carbapenems and gemifloxacin

carbapenems has been researched along with gemifloxacin in 1 studies

Compound Research Comparison

Studies
(carbapenems)
Trials
(carbapenems)
Recent Studies (post-2010)
(carbapenems)
Studies
(gemifloxacin)
Trials
(gemifloxacin)
Recent Studies (post-2010) (gemifloxacin)
7,3551475,2773204680

Protein Interaction Comparison

ProteinTaxonomycarbapenems (IC50)gemifloxacin (IC50)
DNA gyrase subunit BStaphylococcus aureus5.6
DNA gyrase subunit AEscherichia coli K-120.5
DNA gyrase subunit BEscherichia coli K-120.5
DNA topoisomerase 4 subunit AStaphylococcus aureus0.3
DNA gyrase subunit AStaphylococcus aureus5.6

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldstein, EJ1

Other Studies

1 other study(ies) available for carbapenems and gemifloxacin

ArticleYear
Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Sep-01, Volume: 35, Issue:Suppl 1

    Topics: Abdominal Abscess; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Ertapenem; Fluoroquinolones; Gemifloxacin; Humans; Indoles; Lactams; Moxifloxacin; Naphthyridines; Quinolines; Quinolones

2002